scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M |
P698 | PubMed publication ID | 11170281 |
P2093 | author name string | Testa JR | |
London WT | |||
Lin WY | |||
Simon D | |||
Lu YY | |||
Pei J | |||
Fan X | |||
Buetow KH | |||
Balsara BR | |||
Shen FM | |||
De Rienzo A | |||
Tosolini A | |||
P2860 | cites work | Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 | Q24563504 |
HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle | Q24682903 | ||
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 | Q28145752 | ||
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity | Q28284646 | ||
Comparative genomic hybridization and chromosomal instability in solid tumours | Q33653215 | ||
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma | Q33772796 | ||
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma | Q34319319 | ||
Mapping of human chromosomal regions related to neoplasia: Evidence from chromosomes 1 and 17 | Q35054247 | ||
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis | Q35754634 | ||
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. | Q35787051 | ||
Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization | Q36620680 | ||
Centromeric heterochromatin instability of chromosomes 1, 9, and 16 in variable immunodeficiency syndrome--a virus-induced phenomenon? | Q37941119 | ||
Quantitative analysis of comparative genomic hybridization | Q38509783 | ||
Hepatitis B virus. The major etiology of hepatocellular carcinoma | Q39199064 | ||
Loss of heterozygosity in liver tumours | Q40550466 | ||
Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma | Q40681068 | ||
Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis | Q41051463 | ||
Deletion mapping of chromosome 16q in hepatocellular carcinoma | Q41875138 | ||
Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and "jumping translocations" of 1q in a human immunodeficiency virus-related non-Hodgkin's lymphoma | Q45768703 | ||
DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. | Q52179068 | ||
Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma | Q57981011 | ||
Comprehensive allelotyping of human hepatocellular carcinoma | Q57981015 | ||
P433 | issue | 3 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 245-253 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. | |
P478 | volume | 30 |
Q35870437 | Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma |
Q74238775 | Assessment of chromosomal losses and gains in hepatocellular carcinoma |
Q24810951 | Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice |
Q37626035 | Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas |
Q46611676 | Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa |
Q37055721 | Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms |
Q79819006 | Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization |
Q37777019 | Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma. |
Q34693285 | Compilation of published comparative genomic hybridization studies |
Q78368622 | Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss |
Q46584560 | Concordant loss of fragile gene expression early in breast cancer development |
Q54696630 | Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis. |
Q37017089 | Emerging Roles of ADAMTSs in Angiogenesis and Cancer |
Q33874587 | Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas |
Q24647959 | Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma |
Q40488959 | Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells |
Q36735686 | Genetic variation and its role in malignancy |
Q36519006 | Genetics of hepatocellular tumors. |
Q92691404 | Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum |
Q36716630 | Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. |
Q29615767 | Hepatocellular carcinoma pathogenesis: from genes to environment |
Q24803258 | Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data |
Q33350024 | Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization |
Q37295572 | Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3. |
Q74543031 | Molecular pathogenesis of human hepatocellular carcinoma |
Q78357688 | Molecular pathogenesis of human hepatocellular carcinoma |
Q28212534 | PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas |
Q77324206 | Pseudodicentric (16;12)(q11;p11.2) in a type AB (mixed) thymoma |
Q41701970 | Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance |
Q36023775 | Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma |
Q36953585 | The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. |
Search more.